Concepedia

C. Overshiner

CO

11

Publications

596

Citations

11

H-Index

1983

Active since

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

C. Overshiner is an author at Eli Lilly (United States) specializing in social sciences, pharmacotherapy, and neuropharmacology.

Top concepts

Publications per year

1983–2017

11

Publications

11

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine

Eleni T. Tzavara, Frank P. Bymaster, C. Overshiner et al. · Molecular Psychiatry · 2005 · 107 citations

, , +8

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits

J M Witkin, James A. Monn, Darryle D. Schoepp et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 104 citations

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes

Matthew Fell, Jeffrey M. Witkin, Julie F. Falcone et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 99 citations

M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine

Jeffrey M. Witkin, C. Overshiner, X. Li et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 95 citations

The Novel 5-Hydroxytryptamine1A Antagonist LY426965: Effects on Nicotine Withdrawal and Interactions with Fluoxetine

Kurt Rasmussen, David O. Calligaro, Janet F. Czachura et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 58 citations

Rows per page

1–5 of 11